Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Learn how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Italian startup Aptadir has launched with $1.6M to develop drugs targeting DNA hypermethylation for cancer and genetic ...

As numerous trends are currently shaping what is an eventful year for the biotech industry, we have compiled a list of the top European biotech companies that have received sizable seed funding in the ...

GLP-1 analogs are a class of medication intended to lower blood sugar levels and promote weight loss. These molecules, which mimic the action of glucagon-like peptides that are normally produced in ...

Radiopharmaceuticals are a rapidly evolving class of drugs that combine radioactive isotopes with biological molecules to target and treat specific diseases, most notably in oncology and neurology.